Covalent inhibitors for neglected diseases: an exploration of novel Therapeutic options (2023)
Source: Pharmaceuticals. Unidade: FCF
Subjects: DOENÇAS NEGLIGENCIADAS, MALÁRIA, DOENÇA DE CHAGAS
ABNT
ALVES, Erick Tavares Marcelino et al. Covalent inhibitors for neglected diseases: an exploration of novel Therapeutic options. Pharmaceuticals, v. 16, p. 1-14 art. 1028, 2023Tradução . . Disponível em: https://dx.doi.org/10.3390/ph16071028. Acesso em: 14 nov. 2024.APA
Alves, E. T. M., Pernichelle, F. G., Nascimento, L. A. do, Ferreira, G. M., & Ferreira, E. I. (2023). Covalent inhibitors for neglected diseases: an exploration of novel Therapeutic options. Pharmaceuticals, 16, 1-14 art. 1028. doi:10.3390/ph16071028NLM
Alves ETM, Pernichelle FG, Nascimento LA do, Ferreira GM, Ferreira EI. Covalent inhibitors for neglected diseases: an exploration of novel Therapeutic options [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 1028.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.3390/ph16071028Vancouver
Alves ETM, Pernichelle FG, Nascimento LA do, Ferreira GM, Ferreira EI. Covalent inhibitors for neglected diseases: an exploration of novel Therapeutic options [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 1028.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.3390/ph16071028